IL-1α/β and IL-18 profiles and their impact on claudin-1, loricrin and filaggrin expression in patients with atopic dermatitis.

Abstract

Journal of the European Academy of Dermatology and VenereologyAccepted Articles LETTER TO THE EDITOR IL-1α/β and IL-18 profiles and their impact on claudin-1, loricrin and filaggrin expression in patients with atopic dermatitis M. Michaelidou, M. Michaelidou Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Authors contributed equally to this workSearch for more papers by this authorD. Redhu, D. Redhu orcid.org/0000-0002-8423-0844 Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Authors contributed equally to this workSearch for more papers by this authorV. Kumari, V. Kumari Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Authors contributed equally to this workSearch for more papers by this authorM. Babina, M. Babina Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Allergology, Berlin, GermanySearch for more papers by this authorM. Worm, Corresponding Author M. Worm [email protected] Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Correspondence Prof. Dr. med. Margitta Worm Division of Allergy and Immunology Dpt of Dermatology, Venerology and Allergy Campus Charité Mitte, Universitätsmedizin Berlin Charitéplatz 1 D-10117 Berlin Email: [email protected]Search for more papers by this author M. Michaelidou, M. Michaelidou Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Authors contributed equally to this workSearch for more papers by this authorD. Redhu, D. Redhu orcid.org/0000-0002-8423-0844 Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Authors contributed equally to this workSearch for more papers by this authorV. Kumari, V. Kumari Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Authors contributed equally to this workSearch for more papers by this authorM. Babina, M. Babina Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Allergology, Berlin, GermanySearch for more papers by this authorM. Worm, Corresponding Author M. Worm [email protected] Division of Allergy and Immunology, Department of Dermatology and Allergy, Charité Universitätmedizin Berlin, Germany Correspondence Prof. Dr. med. Margitta Worm Division of Allergy and Immunology Dpt of Dermatology, Venerology and Allergy Campus Charité Mitte, Universitätsmedizin Berlin Charitéplatz 1 D-10117 Berlin Email: [email protected]Search for more papers by this author First published: 28 April 2023 https://doi.org/10.1111/jdv.19153 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.19153. AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Accepted ArticlesAccepted, unedited articles published online and citable. The final edited and typeset version of record will appear in the future. RelatedInformation